Cytokines: The Future of Intranasal Vaccine Adjuvants

A Novel Adenovirus Expressing Flt3 Ligand Enhances Mucosal Immunity by Inducing Mature Nasopharyngeal-Associated Lymphoreticular Tissue Dendritic Cell Migration

(2014) S. Sekine et al.   JOURNAL OF IMMUNOLOGY

Influenza Vaccination Acceptance and Refusal Rates Among Health Care Personnel

(2011) Vaughn S. Millner et al.   SOUTHERN MEDICAL JOURNAL

Role of IL-15 in immune-mediated and infectious diseases

(2010) Antonio Di Sabatino et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Interleukin-1 Family Cytokines as Mucosal Vaccine Adjuvants for Induction of Protective Immunity against Influenza Virus

(2010) H. Kayamuro et al.   JOURNAL OF VIROLOGY

Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1

(2010) William M. Gwinn et al.   VACCINE

A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx

(2010) Satoru Kodama et al.   VACCINE

The use of a mutant TNF-α as a vaccine adjuvant for the induction of mucosal immune responses

(2009) Hiroyuki Kayamuro et al.   BIOMATERIALS

Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection

(2009) Jonathan K. Nambiar et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling

(2009) Yeonseok Chung et al.   IMMUNITY

Increase in clinical prevalence of AIDS implies increase in unsafe medical injections

(2009) S Reid   INTERNATIONAL JOURNAL OF STD & AIDS

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

(2009) David J. M. Lewis et al.   PLoS One

Mucosal Immunity: Induction, Dissemination, and Effector Functions

(2009) P. Brandtzaeg   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

(2009) Robert B. Couch et al.   VACCINE

Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken

(2009) Zhang Xiaowen et al.   VACCINE

Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity

(2009) Michaela Prchal et al.   VACCINE

Delivery of interferon-β to the monkey nervous system following intranasal administration

(2008) R.G. Thorne et al.   NEUROSCIENCE

A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity

(2008) Tatsuya Fukuiwa et al.   VACCINE

The Biology of Interleukin-2

(2007) Thomas R. Malek   Annual Review of Immunology

Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis

(2007) Nicola Low et al.   VACCINE